Skip to main content

AIM ImmunoTech Inc.

AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000946644

In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.

13F holders, Q2 2025

Institutional positions in AIM ImmunoTech Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
12
−22 vs. Q1 2025
Shares held
12.1K
−36.2K (−74.9%) vs. Q1 2025Converted for a 1-for-100 split
Total value
$104.8K
−$485.2K (−82.2%) vs. Q1 2025
New holders
2
1 more added
Sold out
24
3 more reduced

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 12 institutions
Q1 2021: 38 institutionsQ2 2021: 39 institutionsQ3 2021: 38 institutionsQ4 2021: 43 institutionsQ1 2022: 38 institutionsQ2 2022: 40 institutionsQ3 2022: 38 institutionsQ4 2022: 39 institutionsQ1 2023: 36 institutionsQ2 2023: 34 institutionsQ3 2023: 38 institutionsQ4 2023: 38 institutionsQ1 2024: 33 institutionsQ2 2024: 36 institutionsQ3 2024: 33 institutionsQ4 2024: 35 institutionsQ1 2025: 34 institutionsQ2 2025: 12 institutionsQ3 2025: 15 institutionsQ4 2025: 13 institutionsQ1 2026: 18 institutionsQ2 2026: 18 institutions
Value heldQ2 2025: $104.8K
Q1 2021: $16.8MQ2 2021: $15.5MQ3 2021: $14.7MQ4 2021: $6.86MQ1 2022: $7.12MQ2 2022: $4.68MQ3 2022: $3.36MQ4 2022: $1.67MQ1 2023: $2.05MQ2 2023: $3.01MQ3 2023: $1.97MQ4 2023: $1.83MQ1 2024: $1.93MQ2 2024: $3.15MQ3 2024: $2.43MQ4 2024: $919.3KQ1 2025: $590.0KQ2 2025: $104.8KQ3 2025: $293.9KQ4 2025: $119.8KQ1 2026: $102.8KQ2 2026: $325.6K
Institutions holding AIM and their total value by quarter
QuarterHoldersValue
Q2 202618$325.6K
Q1 202618$102.8K
Q4 202513$119.8K
Q3 202515$293.9K
Q2 202512$104.8K
Q1 202534$590.0K
Q4 202435$919.3K
Q3 202433$2.43M
Q2 202436$3.15M
Q1 202433$1.93M
Q4 202338$1.83M
Q3 202338$1.97M
Q2 202334$3.01M
Q1 202336$2.05M
Q4 202239$1.67M
Q3 202238$3.36M
Q2 202240$4.68M
Q1 202238$7.12M
Q4 202143$6.86M
Q3 202138$14.7M
Q2 202139$15.5M
Q1 202138$16.8M

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding AIM ImmunoTech Inc.; share changes are against Q1 2025.

Institutions holding AIM in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
CI Private Wealth, LLC10,001$86.5K0.00%+10,001New
UBS Group AG1,181$10.2K0.00%+1,103+1,416.4%AddedConverted for a 1-for-100 split
Morgan Stanley762$6.59K0.00%00.0%UnchangedConverted for a 1-for-100 split
Community Bank, N.A.132$1.14K0.00%00.0%UnchangedConverted for a 1-for-100 split
Hoey Investments, Inc10$870.00%00.0%UnchangedConverted for a 1-for-100 split
Harbour Investments, Inc.10$870.00%00.0%UnchangedConverted for a 1-for-100 split
Advisor Group Holdings, Inc.10$860.00%00.0%UnchangedConverted for a 1-for-100 split
Bank of America Corp5$430.00%−0−0.8%ReducedConverted for a 1-for-100 split
Wells Fargo & Company4$350.00%00.0%UnchangedConverted for a 1-for-100 split
Danske Bank A/S3$260.00%+3New
Steward Partners Investment Advisory, LLC2$170.00%−0−9.1%ReducedConverted for a 1-for-100 split
Farther Finance Advisors, LLC1$90.00%−1−33.3%ReducedConverted for a 1-for-100 split
Vanguard Group Inc0$00.00%−24,443−100.0%Sold outConverted for a 1-for-100 split
BlackRock, Inc.0$00.00%−6,983−100.0%Sold outConverted for a 1-for-100 split
Geode Capital Management, LLC0$00.00%−5,313−100.0%Sold outConverted for a 1-for-100 split
Renaissance Technologies LLC0$00.00%−3,180−100.0%Sold outConverted for a 1-for-100 split
State Street Corp0$00.00%−1,731−100.0%Sold outConverted for a 1-for-100 split
Verition Fund Management LLC0$00.00%−1,620−100.0%Sold outConverted for a 1-for-100 split
Northern Trust Corp0$00.00%−851−100.0%Sold outConverted for a 1-for-100 split
XTX Topco Ltd0$00.00%−835−100.0%Sold outConverted for a 1-for-100 split
Citadel Advisors LLC0$00.00%−487−100.0%Sold outConverted for a 1-for-100 split
Crescent Grove Advisors, LLC0$00.00%−454−100.0%Sold outConverted for a 1-for-100 split
SeaCrest Wealth Management, LLC0$00.00%−351−100.0%Sold outConverted for a 1-for-100 split
Two Sigma Securities, LLC0$00.00%−207−100.0%Sold outConverted for a 1-for-100 split
Captrust Financial Advisors0$00.00%−200−100.0%Sold outConverted for a 1-for-100 split
J.W. Cole Advisors, Inc.0$00.00%−150−100.0%Sold outConverted for a 1-for-100 split
Tower Research Capital LLC (TRC)0$00.00%−143−100.0%Sold outConverted for a 1-for-100 split
D.B. Root & Company, LLC0$00.00%−121−100.0%Sold outConverted for a 1-for-100 split
Traynor Capital Management, Inc.0$00.00%−118−100.0%Sold outConverted for a 1-for-100 split
HB Wealth Management, LLC0$00.00%−100−100.0%Sold outConverted for a 1-for-100 split
TD Waterhouse Canada Inc.0$00.00%−2−100.0%Sold outConverted for a 1-for-100 split
JPMorgan Chase & Co0$00.00%−1−100.0%Sold outConverted for a 1-for-100 split
Huntington National Bank0$00.00%−1−100.0%Sold outConverted for a 1-for-100 split
MAI Capital Management0$00.00%−0−100.0%Sold outConverted for a 1-for-100 split
Royal Bank of Canada0$00.00%−6−100.0%Sold outConverted for a 1-for-100 split
CWM, LLC0$00.00%−0−100.0%Sold outConverted for a 1-for-100 split